Complications after transrectal ultrasound-guided prostate biopsy: A 10-year experience in a single institution

Background: Transrectal ultrasound-guided prostate (TRUS-P) biopsy is the standard diagnostic procedure for patients with suspected prostate cancer. However, infectious complications can occur. Purpose: To analyze the patients from a single institution who were hospitalized for infectious complications after TRUS-P biopsy. Materials and Methods: From 2003 to 2012, 985 TRUS-P biopsy procedures were performed in a medical center in Northern Taiwan; among these, 28 patients were admitted for infectious complications following the procedure. A retrospective review of the medical records was performed, and data regarding the demographics, details of infectious complications, and hospital course of these patients were collected. Results: The median age of the patients was 62 (27–82) years; the comorbidity rate was 57.1% (16/28); the admission rate was 2.8% (28/985). The most common causative pathogen was Escherichia coli. More than half of the cultured E. coli were not resistant to fluoroquinolones. The median hospital stay was 6 (3–16) days, and one patient was admitted to the intensive care unit. No mortality was observed in this study. Although the number of biopsies increased, no obvious increasing trend in the number of hospitalizations was noted in recent years. Conclusion: TRUS-P biopsy can be safely performed, and no obvious increasing trend in infectious complications and resistant strains has been observed in recent years.

• Publication year

  2017

• Venue

  Formosan Journal of Surgery

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/fjs.fjs_32_17
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography‐guided prostate biopsy in reducing infection rates: a systematic review

  2016influential reference
• Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study.

  2015cited by this paper
• Rapid increase in multidrug‐resistant enteric bacilli blood stream infection after prostate biopsy—A 10‐year population‐based cohort study

  2015cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.

  2013cited by this paper
• Systematic review of complications of prostate biopsy.

  2013cited by this paper
• Modification of Antimicrobial Prophylaxis Based on Rectal Culture Results to Prevent Fluoroquinolone-Resistant Escherichia coli Infections after Prostate Biopsy

  2013cited by this paper
• Letters to the Editor/Errata Re: Complications after Prostate Biopsy: Data from SEER-Medicare

  2012cited by this paper
• Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates.

  2012cited by this paper
• Prostate cancer detection and complication rates with transrectal ultrasound-guided prostate biopsies among different operators

  2012cited by this paper
• INFECTION AFTER TRANSRECTAL ULTRASONOGRAPHY‐GUIDED PROSTATE BIOPSY: INCREASED RELATIVE RISKS AFTER RECENT INTERNATIONAL TRAVEL OR ANTIBIOTIC USE

  2012cited by this paper
• Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.

  2012cited by this paper
• Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.

  2011cited by this paper
• Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor.

  2011cited by this paper
• Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

  2010cited by this paper
• Is It Possible to Predict Sepsis, the Most Serious Complication in Prostate Biopsy?

  2009cited by this paper
• Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors.

  2006cited by this paper
• Changing trends of prostate cancer in Asia

  2004cited by this paper

• No citing papers are available for this paper.